Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 45 of 45 entries
Sorted by: Best Match Show Resources per page
A bioinformatic approach to the identification of a conserved domain in a sugarcane legumain that directs GFP to the lytic vacuole.

Functional plant biology : FPB

Jackson MA, Rae AL, Casu RE, Grof CPL, Bonnett GD, Maclean DJ.
PMID: 32689391
Funct Plant Biol. 2007 Aug;34(7):633-644. doi: 10.1071/FP07024.

Sugarcane is an ideal candidate as a biofactory for the production of alternate higher value products. One way of achieving this is to direct useful proteins into the vacuoles within the sugarcane storage parenchyma tissue. By bioinformatic analysis of...

Cite
Jackson MA, Rae AL, Casu RE, et al. A bioinformatic approach to the identification of a conserved domain in a sugarcane legumain that directs GFP to the lytic vacuole. Funct Plant Biol. 2007;34(7):633-644doi: 10.1071/FP07024.
Jackson, M. A., Rae, A. L., Casu, R. E., Grof, C. P. L., Bonnett, G. D., & Maclean, D. J. (2007). A bioinformatic approach to the identification of a conserved domain in a sugarcane legumain that directs GFP to the lytic vacuole. Functional plant biology : FPB, 34(7), 633-644. https://doi.org/10.1071/FP07024
Jackson, Mark A, et al. "A bioinformatic approach to the identification of a conserved domain in a sugarcane legumain that directs GFP to the lytic vacuole." Functional plant biology : FPB vol. 34,7 (2007): 633-644. doi: https://doi.org/10.1071/FP07024
Jackson MA, Rae AL, Casu RE, Grof CPL, Bonnett GD, Maclean DJ. A bioinformatic approach to the identification of a conserved domain in a sugarcane legumain that directs GFP to the lytic vacuole. Funct Plant Biol. 2007 Aug;34(7):633-644. doi: 10.1071/FP07024. PMID: 32689391.
Copy Download .nbib Format: NLM
Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders.

Frontiers in nutrition

van den Brink W, van Bilsen J, Salic K, Hoevenaars FPM, Verschuren L, Kleemann R, Bouwman J, Ronnett GV, van Ommen B, Wopereis S.
PMID: 31508422
Front Nutr. 2019 Aug 26;6:129. doi: 10.3389/fnut.2019.00129. eCollection 2019.

Obesity, type 2 diabetes, and other metabolic disorders have a large impact on global health, especially in Western countries. An important hallmark of metabolic disorders is chronic low-grade inflammation. A key player in chronic low-grade inflammation is dysmetabolism, which...

Cite
van den Brink W, van Bilsen J, Salic K, et al. Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders. Front Nutr. 2019;6:129doi: 10.3389/fnut.2019.00129.
van den Brink, W., van Bilsen, J., Salic, K., Hoevenaars, F. P. M., Verschuren, L., Kleemann, R., Bouwman, J., Ronnett, G. V., van Ommen, B., & Wopereis, S. (2019). Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders. Frontiers in nutrition, 6129. https://doi.org/10.3389/fnut.2019.00129
van den Brink, Willem, et al. "Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders." Frontiers in nutrition vol. 6 (2019): 129. doi: https://doi.org/10.3389/fnut.2019.00129
van den Brink W, van Bilsen J, Salic K, Hoevenaars FPM, Verschuren L, Kleemann R, Bouwman J, Ronnett GV, van Ommen B, Wopereis S. Current and Future Nutritional Strategies to Modulate Inflammatory Dynamics in Metabolic Disorders. Front Nutr. 2019 Aug 26;6:129. doi: 10.3389/fnut.2019.00129. eCollection 2019. PMID: 31508422; PMCID: PMC6718105.
Copy Download .nbib Format: NLM
Plasma Protein and MicroRNA Biomarkers of Insulin Resistance: A Network-Based Integrative -Omics Analysis.

Frontiers in physiology

Choi H, Koh HWL, Zhou L, Cheng H, Loh TP, Parvaresh Rizi E, Toh SA, Ronnett GV, Huang BE, Khoo CM.
PMID: 31024340
Front Physiol. 2019 Apr 05;10:379. doi: 10.3389/fphys.2019.00379. eCollection 2019.

Although insulin resistance (IR) is a key pathophysiologic condition underlying various metabolic disorders, impaired cellular glucose uptake is one of many manifestations of metabolic derangements in the human body. To study the systems-wide molecular changes associated with obesity-dependent IR,...

Cite
Choi H, Koh HWL, Zhou L, et al. Plasma Protein and MicroRNA Biomarkers of Insulin Resistance: A Network-Based Integrative -Omics Analysis. Front Physiol. 2019;10:379doi: 10.3389/fphys.2019.00379.
Choi, H., Koh, H. W. L., Zhou, L., Cheng, H., Loh, T. P., Parvaresh Rizi, E., Toh, S. A., Ronnett, G. V., Huang, B. E., & Khoo, C. M. (2019). Plasma Protein and MicroRNA Biomarkers of Insulin Resistance: A Network-Based Integrative -Omics Analysis. Frontiers in physiology, 10379. https://doi.org/10.3389/fphys.2019.00379
Choi, Hyungwon, et al. "Plasma Protein and MicroRNA Biomarkers of Insulin Resistance: A Network-Based Integrative -Omics Analysis." Frontiers in physiology vol. 10 (2019): 379. doi: https://doi.org/10.3389/fphys.2019.00379
Choi H, Koh HWL, Zhou L, Cheng H, Loh TP, Parvaresh Rizi E, Toh SA, Ronnett GV, Huang BE, Khoo CM. Plasma Protein and MicroRNA Biomarkers of Insulin Resistance: A Network-Based Integrative -Omics Analysis. Front Physiol. 2019 Apr 05;10:379. doi: 10.3389/fphys.2019.00379. eCollection 2019. PMID: 31024340; PMCID: PMC6460474.
Copy Download .nbib Format: NLM
Fructan-hydrolyzing activities from Lolium rigidum Gaudin.

The New phytologist

Bonnett GD, Simpson RJ.
PMID: 33874120
New Phytol. 1993 Mar;123(3):443-451. doi: 10.1111/j.1469-8137.1993.tb03756.x.

Fructan- and sucrose-hydrolyzing activity was extracted from plants of Lolium rigidum Gaudin. Sucrose-hydrolyzing activity varied 30-fold between different plant parts and parts of different ages. In contrast, fructan-hydrolyzing activity only varied two-fold. At least four β-fructofuranosidase activities were partially...

Cite
Bonnett GD, Simpson RJ. Fructan-hydrolyzing activities from Lolium rigidum Gaudin. New Phytol. 1993;123(3):443-451doi: 10.1111/j.1469-8137.1993.tb03756.x.
Bonnett, G. D., & Simpson, R. J. (1993). Fructan-hydrolyzing activities from Lolium rigidum Gaudin. The New phytologist, 123(3), 443-451. https://doi.org/10.1111/j.1469-8137.1993.tb03756.x
Bonnett, G D, and Simpson, R J. "Fructan-hydrolyzing activities from Lolium rigidum Gaudin." The New phytologist vol. 123,3 (1993): 443-451. doi: https://doi.org/10.1111/j.1469-8137.1993.tb03756.x
Bonnett GD, Simpson RJ. Fructan-hydrolyzing activities from Lolium rigidum Gaudin. New Phytol. 1993 Mar;123(3):443-451. doi: 10.1111/j.1469-8137.1993.tb03756.x. PMID: 33874120.
Copy Download .nbib Format: NLM
Epidemiologic Modeling of HIV/AIDS: Use of Computational Models to Study the Population Dynamics of the Disease to Assess Effective Intervention Strategies for Decision-making.

Advances in systems science and applications

Habtemariam T, Tameru B, Nganwa D, Beyene G, Ayanwale L, Robnett V.
PMID: 25411545
Adv Syst Sci Appl. 2008 Mar;8(1):35-39.

Computational models and simulations are becoming central research tools in epidemiology, biology, and other fields. Epidemiologic research involves the study of a complex set of host, environment and causative agent factors as these interact to impact health and diseases...

Cite
Habtemariam T, Tameru B, Nganwa D, et al. Epidemiologic Modeling of HIV/AIDS: Use of Computational Models to Study the Population Dynamics of the Disease to Assess Effective Intervention Strategies for Decision-making. Adv Syst Sci Appl. 2008;8(1):35-39
Habtemariam, T., Tameru, B., Nganwa, D., Beyene, G., Ayanwale, L., & Robnett, V. (2008). Epidemiologic Modeling of HIV/AIDS: Use of Computational Models to Study the Population Dynamics of the Disease to Assess Effective Intervention Strategies for Decision-making. Advances in systems science and applications, 8(1), 35-39.
Habtemariam, T, et al. "Epidemiologic Modeling of HIV/AIDS: Use of Computational Models to Study the Population Dynamics of the Disease to Assess Effective Intervention Strategies for Decision-making." Advances in systems science and applications vol. 8,1 (2008): 35-39.
Habtemariam T, Tameru B, Nganwa D, Beyene G, Ayanwale L, Robnett V. Epidemiologic Modeling of HIV/AIDS: Use of Computational Models to Study the Population Dynamics of the Disease to Assess Effective Intervention Strategies for Decision-making. Adv Syst Sci Appl. 2008 Mar;8(1):35-39. PMID: 25411545; PMCID: PMC4234121.
Copy Download .nbib Format: NLM
Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging.

Archives of pathology & laboratory medicine

Gavrielides MA, Ronnett BM, Vang R, Barak S, Lee E, Staats PN, Jenson E, Skaria P, Sheikhzadeh F, Miller M, Hagemann IS, Petrick N, Seidman JD.
PMID: 33635941
Arch Pathol Lab Med. 2021 Dec 01;145(12):1516-1525. doi: 10.5858/arpa.2020-0579-OA.

CONTEXT.—: Despite several studies focusing on the validation of whole slide imaging (WSI) across organ systems or subspecialties, the use of WSI for specific primary diagnosis tasks has been underexamined.OBJECTIVE.—: To assess pathologist performance for the histologic subtyping of...

Cite
Gavrielides MA, Ronnett BM, Vang R, et al. Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging. Arch Pathol Lab Med. 2021;145(12):1516-1525doi: 10.5858/arpa.2020-0579-OA.
Gavrielides, M. A., Ronnett, B. M., Vang, R., Barak, S., Lee, E., Staats, P. N., Jenson, E., Skaria, P., Sheikhzadeh, F., Miller, M., Hagemann, I. S., Petrick, N., & Seidman, J. D. (2021). Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging. Archives of pathology & laboratory medicine, 145(12), 1516-1525. https://doi.org/10.5858/arpa.2020-0579-OA
Gavrielides, Marios A, et al. "Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging." Archives of pathology & laboratory medicine vol. 145,12 (2021): 1516-1525. doi: https://doi.org/10.5858/arpa.2020-0579-OA
Gavrielides MA, Ronnett BM, Vang R, Barak S, Lee E, Staats PN, Jenson E, Skaria P, Sheikhzadeh F, Miller M, Hagemann IS, Petrick N, Seidman JD. Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging. Arch Pathol Lab Med. 2021 Dec 01;145(12):1516-1525. doi: 10.5858/arpa.2020-0579-OA. PMID: 33635941.
Copy Download .nbib Format: NLM
A framework for analysing nitrification inhibition: A case study on 3,4-dimethylpyrazole phosphate (DMPP).

The Science of the total environment

Vilas MP, Verburg K, Thorburn PJ, Probert ME, Bonnett GD.
PMID: 30978546
Sci Total Environ. 2019 Jul 01;672:846-854. doi: 10.1016/j.scitotenv.2019.03.462. Epub 2019 Apr 05.

Nitrification inhibitors show great potential to reduce nitrogen losses from agricultural systems and to improve nitrogen use efficiency. The most recently developed nitrification inhibitor 3,4-dimethylpyrazole phosphate (DMPP) is gaining popularity due to its benefits relative to other compounds. However,...

Cite
Vilas MP, Verburg K, Thorburn PJ, et al. A framework for analysing nitrification inhibition: A case study on 3,4-dimethylpyrazole phosphate (DMPP). Sci Total Environ. 2019;672:846-854doi: 10.1016/j.scitotenv.2019.03.462.
Vilas, M. P., Verburg, K., Thorburn, P. J., Probert, M. E., & Bonnett, G. D. (2019). A framework for analysing nitrification inhibition: A case study on 3,4-dimethylpyrazole phosphate (DMPP). The Science of the total environment, 672846-854. https://doi.org/10.1016/j.scitotenv.2019.03.462
Vilas, M P, et al. "A framework for analysing nitrification inhibition: A case study on 3,4-dimethylpyrazole phosphate (DMPP)." The Science of the total environment vol. 672 (2019): 846-854. doi: https://doi.org/10.1016/j.scitotenv.2019.03.462
Vilas MP, Verburg K, Thorburn PJ, Probert ME, Bonnett GD. A framework for analysing nitrification inhibition: A case study on 3,4-dimethylpyrazole phosphate (DMPP). Sci Total Environ. 2019 Jul 01;672:846-854. doi: 10.1016/j.scitotenv.2019.03.462. Epub 2019 Apr 05. PMID: 30978546.
Copy Download .nbib Format: NLM
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.

The Lancet. Infectious diseases

Goldstone SE, Giuliano AR, Palefsky JM, Lazcano-Ponce E, Penny ME, Cabello RE, Moreira ED, Baraldi E, Jessen H, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Bautista O, Das R, Group T, Luxembourg A, Zhou HJ, Saah A.
PMID: 34780705
Lancet Infect Dis. 2021 Nov 12; doi: 10.1016/S1473-3099(21)00327-3. Epub 2021 Nov 12.

BACKGROUND: The quadrivalent human papillomavirus (HPV) vaccine was shown to prevent infections and lesions related to HPV6, 11, 16, and 18 in a randomised, placebo-controlled study in men aged 16-26 years. We assessed the incidences of external genital warts...

Cite
Goldstone SE, Giuliano AR, Palefsky JM, et al. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2021;doi: 10.1016/S1473-3099(21)00327-3.
Goldstone, S. E., Giuliano, A. R., Palefsky, J. M., Lazcano-Ponce, E., Penny, M. E., Cabello, R. E., Moreira, E. D., Baraldi, E., Jessen, H., Ferenczy, A., Kurman, R., Ronnett, B. M., Stoler, M. H., Bautista, O., Das, R., Group, T., Luxembourg, A., Zhou, H. J., & Saah, A. (2021). Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. The Lancet. Infectious diseases, . https://doi.org/10.1016/S1473-3099(21)00327-3
Goldstone, Stephen E, et al. "Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial." The Lancet. Infectious diseases vol. (2021). doi: https://doi.org/10.1016/S1473-3099(21)00327-3
Goldstone SE, Giuliano AR, Palefsky JM, Lazcano-Ponce E, Penny ME, Cabello RE, Moreira ED, Baraldi E, Jessen H, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Bautista O, Das R, Group T, Luxembourg A, Zhou HJ, Saah A. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2021 Nov 12; doi: 10.1016/S1473-3099(21)00327-3. Epub 2021 Nov 12. PMID: 34780705.
Copy Download .nbib Format: NLM
Rare Complete Hydatidiform Mole With p57 Expression in Villous Mesenchyme: Case Report and Review of Discordant p57 Expression in Hydatidiform Moles.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Murphy KM, Carrick K, Gwin K, Rogers V, Koduru P, Ronnett BM, Castrillon DH.
PMID: 33900230
Int J Gynecol Pathol. 2022 Jan 01;41(1):45-50. doi: 10.1097/PGP.0000000000000773.

Complete hydatidiform mole (CHM) is a premalignant proliferative disease of the placenta characterized by misexpression of imprinted gene products, most notably p57. The majority of CHM exhibit immunohistochemical absence of p57 protein in villous mesenchyme (VM) and cytotrophoblast (CT)...

Cite
Murphy KM, Carrick K, Gwin K, et al. Rare Complete Hydatidiform Mole With p57 Expression in Villous Mesenchyme: Case Report and Review of Discordant p57 Expression in Hydatidiform Moles. Int J Gynecol Pathol. 2022;41(1):45-50doi: 10.1097/PGP.0000000000000773.
Murphy, K. M., Carrick, K., Gwin, K., Rogers, V., Koduru, P., Ronnett, B. M., & Castrillon, D. H. (2022). Rare Complete Hydatidiform Mole With p57 Expression in Villous Mesenchyme: Case Report and Review of Discordant p57 Expression in Hydatidiform Moles. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 41(1), 45-50. https://doi.org/10.1097/PGP.0000000000000773
Murphy, Kathleen M, et al. "Rare Complete Hydatidiform Mole With p57 Expression in Villous Mesenchyme: Case Report and Review of Discordant p57 Expression in Hydatidiform Moles." International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists vol. 41,1 (2022): 45-50. doi: https://doi.org/10.1097/PGP.0000000000000773
Murphy KM, Carrick K, Gwin K, Rogers V, Koduru P, Ronnett BM, Castrillon DH. Rare Complete Hydatidiform Mole With p57 Expression in Villous Mesenchyme: Case Report and Review of Discordant p57 Expression in Hydatidiform Moles. Int J Gynecol Pathol. 2022 Jan 01;41(1):45-50. doi: 10.1097/PGP.0000000000000773. PMID: 33900230.
Copy Download .nbib Format: NLM
Showing 37 to 45 of 45 entries